[1]
Styczkiewicz, K., Plata, P. and PolityƄska, K. 2026. Should age disqualify from life-prolonging therapy? Successful adjuvant immunotherapy in an 88-year-old octogenarian with melanoma and high cardiovascular risk . OncoReview. (Jul. 2026). DOI:https://doi.org/10.24292/01.OR.164222226.